Holders — by stockHoldings — by fund
Exome Asset Management LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002011932
$162.1M
disclosed book value
52
positions
6.2%
largest position share
Positions, as of 2026-06-30
top 52 of 52 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | GHGUARDANT HEALTH INC | 67,500 | $10.1M | 6.2% |
| 2 | PRAXPRAXIS PRECISION MEDICINES I | 27,205 | $9.1M | 5.6% |
| 3 | TGTXTG THERAPEUTICS INC | 164,915 | $9.1M | 5.6% |
| 4 | COGTCOGENT BIOSCIENCES INC | 210,523 | $8.1M | 5% |
| 5 | IONSIONIS PHARMACEUTICALS INC | 88,177 | $7.0M | 4.3% |
| 6 | LLYELI LILLY & CO | 5,492 | $6.6M | 4.1% |
| 7 | ABVXABIVAX SA | 46,878 | $6.2M | 3.9% |
| 8 | ALMSALUMIS INC | 204,418 | $5.8M | 3.5% |
| 9 | CYTKCYTOKINETICS INC | 60,056 | $5.1M | 3.2% |
| 10 | ELVNENLIVEN THERAPEUTICS INC | 100,203 | $5.1M | 3.1% |
| 11 | VERAVERA THERAPEUTICS INC | 97,276 | $4.2M | 2.6% |
| 12 | UNHUNITEDHEALTH GROUP INC | 9,612 | $4.0M | 2.5% |
| 13 | TXG10X GENOMICS INC | 102,629 | $3.9M | 2.4% |
| 14 | NTRANATERA INC | 13,800 | $3.7M | 2.3% |
| 15 | UNIQURE NV | 81,056 | $3.7M | 2.3% |
| 16 | RYTMRHYTHM PHARMACEUTICALS INC | 32,209 | $3.6M | 2.2% |
| 17 | MAZEMAZE THERAPEUTICS INC | 114,692 | $3.4M | 2.1% |
| 18 | GLUEMONTE ROSA THERAPEUTICS INC | 137,115 | $3.3M | 2% |
| 19 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 166,493 | $3.2M | 2% |
| 20 | ALKERMES PLC | 61,336 | $3.2M | 2% |
| 21 | LQDALIQUIDIA CORPORATION | 39,224 | $3.1M | 1.9% |
| 22 | UTHRUNITED THERAPEUTICS CORP DEL | 5,410 | $2.9M | 1.8% |
| 23 | GKOSGLAUKOS CORP | 19,862 | $2.8M | 1.7% |
| 24 | ARWRARROWHEAD PHARMACEUTICALS IN | 32,214 | $2.6M | 1.6% |
| 25 | AGIOAGIOS PHARMACEUTICALS INC | 70,500 | $2.6M | 1.6% |
| 26 | CRESCENT BIOPHARMA INC. | 127,769 | $2.3M | 1.4% |
| 27 | ASTRAZENECA PLC | 12,045 | $2.3M | 1.4% |
| 28 | BSXBOSTON SCIENTIFIC CORP | 48,347 | $2.1M | 1.3% |
| 29 | ADAGADAGENE INC | 488,293 | $2.1M | 1.3% |
| 30 | PENPENUMBRA INC | 6,300 | $2.0M | 1.2% |
| 31 | ISRGINTUITIVE SURGICAL INC | 4,908 | $2.0M | 1.2% |
| 32 | VKTXVIKING THERAPEUTICS INC | 47,861 | $1.9M | 1.2% |
| 33 | OCULOCULAR THERAPEUTIX INC | 181,588 | $1.8M | 1.1% |
| 34 | EQEQUILLIUM INC | 552,956 | $1.8M | 1.1% |
| 35 | ASCENDIS PHARMA A/S | 6,573 | $1.8M | 1.1% |
| 36 | CRBPCORBUS PHARMACEUTICALS HLDGS | 184,914 | $1.7M | 1.1% |
| 37 | CTMXCYTOMX THERAPEUTICS INC. | 460,067 | $1.7M | 1.1% |
| 38 | VSTMVERASTEM INC | 429,041 | $1.6M | 1% |
| 39 | NKTRNEKTAR THERAPEUTICS | 22,417 | $1.6M | 1% |
| 40 | CLPTCLEARPOINT NEURO INC | 83,636 | $1.5M | 0.9% |
| 41 | INSMINSMED INC | 13,873 | $1.5M | 0.9% |
| 42 | CAICARIS LIFE SCIENCES INC | 78,180 | $1.4M | 0.9% |
| 43 | BBIOBRIDGEBIO PHARMA INC | 18,359 | $1.4M | 0.8% |
| 44 | ZBIOZENAS BIOPHARMA INC | 52,443 | $1.3M | 0.8% |
| 45 | NBPNOVABRIDGE BIOSCIENCES | 576,960 | $1.1M | 0.7% |
| 46 | ESTABLISHMENT LABS HLDGS INC | 13,100 | $1.1M | 0.7% |
| 47 | RLAYRELAY THERAPEUTICS INC | 47,531 | $889,305 | 0.5% |
| 48 | GERNGERON CORP | 624,046 | $798,779 | 0.5% |
| 49 | DRUGBRIGHT MINDS BIOSCIENCES INC | 10,110 | $709,722 | 0.4% |
| 50 | CMPXCOMPASS THERAPEUTICS INC | 276,165 | $604,801 | 0.4% |
| 51 | REPLREPLIMUNE GROUP INC | 40,361 | $446,796 | 0.3% |
| 52 | ABUSARBUTUS BIOPHARMA CORP | 50,166 | $240,797 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.